[1]Locationinpatent:experimentalpartLiu,Xiao;Tian,Zhicheng;Chen,Chen;Allcock,HarryR.[Macromolecules,2012,vol.45,#3,p.1417-1426]
[2]Tian,Zhicheng;Chen,Chen;Allcock,HarryR.[Macromolecules,2014,vol.47,#3,p.1065-1072]
[3]Acerete,Carmen;Bueno,JoseM.;Campayo,Lucrecia;Navarro,Pilar;IsabelRodriguez-Franco;Samat,Andre[Tetrahedron,1994,vol.50,#16,p.4765-4774]
[4]Yue,Xuyi;Taraban,MarcB.;Hyland,LauraL.;Yu,YihuaBruce[JournalofOrganicChemistry,2012,vol.77,#20,p.8879-8887]
[5]Lee,SangKwang;Park,MinKyun;Jhang,HoEun;Yi,Jinju;Nahm,Keepyong;Cho,DaeWon;Ra,ChoonSup;Musilek,Kamil;Horova,Anna;Korabecny,Jan;Dolezal,Rafael;Jun,Daniel;Kuca,KamilKuca[BulletinoftheKoreanChemicalSociety,2015,vol.36,#6,p.1654-1660]
[6]Locationinpatent:schemeortableGuenet,Aurelie;ErnestGraf;NathalieKyritsakas;Hosseini,MirWais[InorganicChemistry,2010,vol.49,#4,p.1872-1883]
[7]Harada,Norihiro;Nishiyama,Shingo;Kanazawa,Masakatsu;Tsukada,Hideo[Journaloflabelledcompoundsandradiopharmaceuticals,2013,vol.56,#11,p.553-561]
[8]CurrentPatentAssignee:HAMAMATSUPHOTONICSKK-US2015/225368,2015,A1Locationinpatent:Paragraph0066;0067;0068
[9]CurrentPatentAssignee:HAMAMATSUPHOTONICSKK-US2016/256578,2016,A1Locationinpatent:Paragraph0078;0079;0080
[10]CurrentPatentAssignee:COCRYSTALPHARMA,INC.-WO2016/154241,2016,A1Locationinpatent:Paragraph231;234
[11]CurrentPatentAssignee:COCRYSTALPHARMA,INC.-WO2018/200425,2018,A1Locationinpatent:Paragraph00290
[12]CurrentPatentAssignee:COCRYSTALPHARMA,INC.-WO2020/23813,2020,A1Locationinpatent:Paragraph00271
[13]Chou,Teh-Chang;Chen,Shing-Yi;Chen,Yie-Hsung[Tetrahedron,2003,vol.59,#50,p.9939-9950]
[1]CurrentPatentAssignee:UNIVERSITYSYSTEMOFMARYLAND-US2013/197271,2013,A1Locationinpatent:Paragraph0105
[2]Kato,Ryosuke;Watanabe,Hiroyuki;Morisaki,Yasuhiro;Chujo,Yoshiki[Heterocycles,2015,vol.91,#12]
182924-36-3
[1]Patent:WO2016/154241,2016,A1.Locationinpatent:Paragraph578;585
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
